Life Spine Reports the US FDA’s Approval of the ARx SAI Spinal Fixation System
Shots:
- The US FDA has granted 510(k) clearance to the company’s ARx SAI (Sacral Alar Iliac) Spinal Fixation System
- The system is developed for use through a Sacral Alar Iliac trajectory in S1 and/or S2 to enable max. sacroiliac joint fixation. Its versatile implants, combined with ergonomic instruments, offer customized solutions for each patient's specific pathology
- The system’s features & advantages include self-drilling screws (to increase efficiency & save time), a self-harvesting design (that packs bone during insertion), a low-profile cobalt chrome tulip head (that offers high strength for all patient sizes) & universal T25 hexalobe drive
Ref: Life Spine | Image: Life Spine
Related News:- THINK Surgical Gains the US FDA’s Approval for TMINI Miniature Robotic System (TMINI 1.1)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
